About this episode
A revolution is underway in cancer diagnosis. A gene-based test called next-generation sequencing can identify precise mutations in a patient’s DNA, which can then be treated with targeted therapies instead of painful chemotherapy. For an 80-year-old woman with stage 4 lung cancer, it meant walking again. For a 24-year-old with breast cancer, it meant a normal life. But since NGS tests can cost up to Rs 4 lakh, a unique collaboration called LuNGS Alliance is making it free for lung cancer patients across India — offering a glimpse of how medical breakthroughs can be made accessible and affordable for all.
Vikas Dandekar and Arijit Barman report. Anirban Chowdhury narrates for audio
Listen in.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time The Morning Brief publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Morning Brief
J.P.Morgan’s Anu Aiyengar on Mega Deals, AI’s Banking Reset and the India Bet
The Morning Brief
ET Deep Dive: When Development Turns Disaster
The Morning Brief
Subrata Mitra on India’s VC Reset, the AI Capital Race and What Comes Next
The Morning Brief
HDFC Bank’s CEO Hunt
The Morning Brief